Skip to content
HCW Biologics
  • About Us
    • Our Company
    • Leadership and Board
  • The Science
    • Inflammaging
    • Our Technology
  • Our Focus
    • Chronic Inflammation
    • Pipeline
  • Our Publications
    • Scientific Publications
    • Posters
  • Contact
    • General Inquiries
    • Careers
  • Investors
    • Corporate Profile
    • Corporate Presentation
    • News Releases
    • Events and Posters
    • SEC Filings
HCW Biologics
  • About Us
    • Our Company
    • Leadership and Board
  • The Science
    • Inflammaging
    • Our Technology
  • Our Focus
    • Chronic Inflammation
    • Pipeline
  • Our Publications
    • Scientific Publications
    • Posters
  • Contact
    • General Inquiries
    • Careers
  • Investors
    • Corporate Profile
    • Corporate Presentation
    • News Releases
    • Events and Posters
    • SEC Filings

Publications

A "Prime and Expand" Strategy Using the Multifunctional Fusion Proteins to Generate Memory-Like NK Cells for Cell Therapy

Cancer Immunology, Immunotherapy, Shrestha N. et al., July 3rd , 2024

  • Publications

Immunotherapeutic Approach to Reduce Senescent Cells and Alleviate Senescence-Associated Secretory Phenotype in Mice

Aging Cell, Shrestha N. et al., March 26th, 2023

  • Publications

A Novel Interleukin-2-Based Fusion Molecule, HCW9302, Differentially Promotes Regulatory T Cell Expansion to Treat Atherosclerosis in Mice

Frontiers in Immunology, Zhu X. et al., January 25th, 2023

  • Publications

Immunotherapeutic HCW9218 Augments Anti-tumor Activity of Chemotherapy via NK Cell Mediated Reduction of Therapy Induced Senescent Cells

Molecular Therapy, Chaturvedi P. et al., January 17th, 2022

  • Publications

Bifunctional TGF-β trap/IL-15 Protein Complex Elicits Potent NK Cell and CD8+ T Cell Immunity Against Solid Tumors

Molecular Therapy, Liu B. et al., October 6th, 2021

  • Publications

A Fusion Protein Complex that Combines IL12, IL15, and IL18 Signaling to Induce Memory-like NK Cells for Cancer Immunotherapy

Cancer Immunol Res, Becker-Hapak M. et al., September 9th, 2021

  • Publications
Menu
  • About Us
    • Our Company
    • Leadership and Board
  • The Science
    • Inflammaging
    • Our Technology
  • Our Focus
    • Chronic Inflammation
    • Pipeline
  • Our Publications
    • Scientific Publications
    • Posters
  • Contact
    • General Inquiries
    • Careers
  • Investors
    • Corporate Profile
    • Corporate Presentation
    • News Releases
    • Events and Posters
    • SEC Filings

Copyright © 2021-2025 HCW Biologics Inc.

| Privacy Policy

Cleantalk Pixel